PSY180 - UK HEALTH TECHNOLOGY ASSESSMENT OF ORPHAN DRUGS FOR RARE ONCOLOGY VERSUS RARE DISEASE- DOES ORPHAN DESIGNATION MAKE ANY DIFFERENCE IN HTA PROCESS?
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2754
https://www.valueinhealthjournal.com/article/S1098-3015(18)36056-X/fulltext
Section Title :
Section Order :
2111
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36056-X&doi=10.1016/j.jval.2018.09.2754